Standard Biotools Debt-to-Equity Ratio Growth & History (LAB)

Standard Biotools's debt-to-equity ratio was 0.07 for fiscal 2025.

View full Standard Biotools company overview

Standard Biotools annual debt-to-equity ratio history

Standard Biotools annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.070.00+3.87%
20242024-12-310.07
20212021-12-310.430.13+45.03%
20202020-12-310.300.26+638.48%
20192019-12-310.040.04
20182018-12-310.00−6.31
20172017-12-316.316.31
20162016-12-310.000.00
20152015-12-310.000.00
20142014-12-310.000.00
20132013-12-310.000.00
20122012-12-310.00−0.18
20112011-12-310.18

Standard Biotools debt-to-equity ratio trends

Over the last five fiscal years, Standard Biotools's debt-to-equity ratio decreased from 0.30 to 0.07, a change of −0.22. The latest reported quarter, Q2 2026, shows 0.05.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Standard Biotools source filings ↗

Community posts

It’s quiet here.

No posts about LAB yet. Start the conversation.

Write the first post